Tailored Prokinetic Therapy in Gastroparesis Using Gastric Emptying and Contractility
Neurogastroenterology & Motility · 2026-10 · 38 (10)
DOI: 10.1111/nmo.70463 ↗At a glance
Klinische Studie in Neurogastroenterology & Motility, published online on 2026-10-12. Written by Jonathan Kuang Ziyang and 2 co-authors. Institution: Department of Gastroenterology and Hepatology, Tan Tock Seng Hospital, Singapore, Singapore. Major MEDLINE topics: Gastric Emptying, Gastrointestinal Agents, Gastroparesis, Muscle Contraction. 30 references. Funded by: Medtronic.
Abstract (original language)
Background and Aims Physiologic biomarkers to predict prokinetic response in patients with gastroparesis‐like symptoms are needed to better tailor management. This study aims to investigate phenotypes of antral high‐amplitude contraction (HAC) counts relative to gastric emptying delay in patients with upper gastrointestinal (UGI) symptoms and examine response to prokinetics.
Methods
We retrospectively analyzed patients with UGI symptoms undergoing wireless motility capsule (WMC) testing. Data were collected on demographics, gastric emptying time (GET), Gastroparesis Cardinal Symptom Index (GCSI) scores, and prokinetic use. The number of HACs during a fasting period was counted. A single HAC was defined as a pressure amplitude > 65 mmHg within 20 min. Subjects were classified based on GET and HAC counts. The Wilcoxon signed‐rank test compared GCSI scores at baseline and 6 months, in those with and without prokinetic use.
Results
In 135 patients, four distinct phenotypes were identified: non‐delayed GET non‐elevated HAC count (54.8%), non‐delayed GET elevated HAC count (9.6%), delayed GET non‐elevated HAC count (20.7%), and delayed GET elevated HAC count (14.8%). A total of 48.1% of all patients were on prokinetics. Those with delayed GET and elevated HAC counts showed significant improvement in GCSI scores only in subjects using prokinetics (2.95 vs. 1.98, diff −0.98, p = 0.03). In non‐delayed GET, non‐elevated HAC count, GCSI scores improved both with (2.61 vs. 1.68, diff −0.93, p < 0.01) and without (2.47 vs. 1.87, diff −0.61, p < 0.01) prokinetics.
Conclusion
We identified a specific phenotype of delayed GET elevated HAC count, representing patients with poor capsule exiting efficiency, which could be a biomarker for tailored prokinetic therapy. Trial Registration NCT02022826
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Gastroenterology and Hepatology, Tan Tock Seng Hospital, Singapore, Singapore.
- Center for Neurointestinal Health, Gastroenterology Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Digestive Liver Disease Division, Columbia University Medical Center, New York, New York, USA.
ORCID profiles: Jonathan Kuang Ziyang, Braden Kuo, Brian Surjanhata
Funding
- Medtronic
Cite
APA
Ziyang, J. K., Kuo, B., & Surjanhata, B. (2026). Tailored Prokinetic Therapy in Gastroparesis Using Gastric Emptying and Contractility. Neurogastroenterology & Motility, 38(10). https://doi.org/10.1111/nmo.70463
Vancouver
Ziyang JK, Kuo B, Surjanhata B. Tailored Prokinetic Therapy in Gastroparesis Using Gastric Emptying and Contractility. Neurogastroenterology & Motility. 2026;38(10). doi:10.1111/nmo.70463
BibTeX
@article{Ziyang2026,
author = {Ziyang, Jonathan Kuang and Kuo, Braden and Surjanhata, Brian},
title = {Tailored Prokinetic Therapy in Gastroparesis Using Gastric Emptying and Contractility},
journal = {Neurogastroenterology & Motility},
year = {2026},
volume = {38},
number = {10},
doi = {10.1111/nmo.70463}
}
EUVIMED